Prapela Receives FDA’s Breakthrough Device Designation to Investigate the Use of Stimulation to Treat Apnea of Prematurity
FDA Breakthrough Device Designations speed up the development and review of medical devices that can improve the lives of people with life-threatening or debilitating conditions. Every year, approximately 1.6 million newborns will experience clinically significant apnea. Prapela’s stimulation pad could... Read More →
Zimmer Biomet to Acquire Embody, Inc.
Deal Strengthens Zimmer Biomet’s Growing Sports Medicine Portfolio and Supports Continued Company Transformation WARSAW, Ind., Jan. 5, 2023 /PRNewswire/ — Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, today announced that it has reached a... Read More →
Mayo Clinic takes a stake in PillBot developer Endiatx
Mayo Clinic and Endiatx have signed a know-how license agreement covering the ongoing development of Endiatx’s PillBot. The deal gives Mayo Clinic an equity stake in the robotic stomach camera startup, Endiatx co-founder and CEO Torrey Smith told MassDevice. He... Read More →
Garwood Medical Devices, LLC named as an Awardee in the Innovations for Vets QuickFire Challenge Innovation
BUFFALO, NY – December 16, 2022, Garwood Medical Devices, LLC has been selected as an awardee of the Innovations for Vets Quickfire Challenge launched by Johnson & Johnson Innovation – JLABS with the Johnson & Johnson Office of Military and... Read More →
Anumana and Pfizer Partner to Enable Early Detection of Underdiagnosed Cardiovascular Disease
Companies initiate research agreement supporting development of new AI-ECG algorithm to help identify patients who may be at risk of cardiac amyloidosis CAMBRIDGE, Mass.–(BUSINESS WIRE)–Anumana, Inc., an AI-driven health technology company and portfolio company of nference, has entered into a... Read More →
CardiaCare Announces Licensing and Distribution Agreement to Commercialize its Digital Neuromodulation Wearable for Non-invasive Atrial Fibrillation Treatment
REHOVOT, Israel, Dec. 15, 2022 /PRNewswire/ — CardiaCare, a clinical stage digital therapeutic company developing the world’s first non-invasive, personalized neuromodulation wearable for atrial fibrillation treatment, announced today the execution of a strategic licensing agreement with Dr. Reddy’s Laboratories, a... Read More →
Confronting EtO sterilization with Phiex Technologies CEO CL Tian
EPA shutdowns and a mammoth plaintiff settlement against Ethylene Oxide (EtO) created a logistical nightmare for the medical device industry. Phiex Technologies co-founder & CEO CL Tian and her team are on a mission to change all that. Most medical... Read More →
AuriGen Medical crowdfunds nearly €3m in three weeks
AuriGen Medical, an Irish medical devices start-up has raised almost €3 million through crowdfunding in just three weeks. The company, which is based at NUI Galway has developed a heart implant designed to treat both the stroke and arrhythmia risk... Read More →
Cardiosense, Inc., Completes $15.1 Million Series A Financing to Advance Artificial Intelligence Platform for Heart Disease
CHICAGO, Dec. 8, 2022 /PRNewswire/ — Cardiosense, Inc., a Chicago-based digital health company leveraging artificial intelligence and multi-sensor devices to enable early detection of cardiovascular disease, announced today that it has raised $15.1 million in Series A funding, co-led by... Read More →
Money Moves: iECURE, Avisi Technologies and Invent Analytics just scored $75M+ in venture capital
Take note of these November and December announcements, including a $65 Series A for Penn gene-editing spinout iECURE. Plus, the Center for Diagnostics Discovery is launching in Horsham. Avisi Technologies raised a seed round Medtech startup Avisi Technologies has raised... Read More →